172 related articles for article (PubMed ID: 37476382)
1. Hypermethylated
Lukacova E; Burjanivova T; Podlesniy P; Grendar M; Turyova E; Kasubova I; Laca L; Mikolajcik P; Kudelova E; Vanochova A; Miklusica J; Mersakova S; Lasabova Z
Front Oncol; 2023; 13():1205791. PubMed ID: 37476382
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
[TBL] [Abstract][Full Text] [Related]
3. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
[TBL] [Abstract][Full Text] [Related]
4. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
[TBL] [Abstract][Full Text] [Related]
5. Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma.
Beinse G; Borghese B; Métairie M; Just PA; Poulet G; Garinet S; Parfait B; Didelot A; Bourreau C; Agueeff N; Lavollé A; Terris B; Chapron C; Goldwasser F; Leroy K; Blons H; Laurent-Puig P; Taly V; Alexandre J
Clin Chem; 2022 Jun; 68(6):782-793. PubMed ID: 35323926
[TBL] [Abstract][Full Text] [Related]
6. Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer.
Li D; Bai Y; Feng Z; Li W; Yang C; Guo Y; Lin C; Zhang Y; He Q; Hu G; Li X
Front Oncol; 2019; 9():394. PubMed ID: 31165042
[TBL] [Abstract][Full Text] [Related]
7. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Value of
Picardo F; Romanelli A; Muinelo-Romay L; Mazza T; Fusilli C; Parrella P; Barbazán J; Lopez-López R; Barbano R; De Robertis M; Taffon C; Bordoni V; Agrati C; Costantini M; Ricci F; Graziano P; Maiello E; Muscarella LA; Fazio VM; Poeta ML
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635093
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
10. The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases.
Cohen SA; Yu M; Baker K; Redman M; Wu C; Heinzerling TJ; Wirtz RM; Charalambous E; Pentheroudakis G; Kotoula V; Kalogeras KT; Fountzilas G; Grady WM
Clin Epigenetics; 2017; 9():46. PubMed ID: 28469732
[TBL] [Abstract][Full Text] [Related]
11. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.
Hauptman N; Jevšinek Skok D; Spasovska E; Boštjančič E; Glavač D
BMC Med Genomics; 2019 Apr; 12(1):54. PubMed ID: 30987631
[TBL] [Abstract][Full Text] [Related]
12. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
14. A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps.
Hokazono K; Ueki T; Nagayoshi K; Nishioka Y; Hatae T; Koga Y; Hirahashi M; Oda Y; Tanaka M
Oncol Lett; 2014 Nov; 8(5):1937-1944. PubMed ID: 25289081
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
16. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract][Full Text] [Related]
17. Detection of
Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
[TBL] [Abstract][Full Text] [Related]
18. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
19. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
20.
Wang C; Liu Y; Guo W; Zhu X; Ahuja N; Fu T
Cancer Manag Res; 2019; 11():7337-7343. PubMed ID: 31496795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
